ERASX | TRQZX | ERASX / TRQZX | |
Total Expense Ratio | 0.81 | 0.00 | - |
Annual Report Gross Expense Ratio | 0.81 | 0.61 | 133% |
Fund Existence | 11 years | 6 years | - |
Gain YTD | -4.780 | 3.028 | -158% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14B | 26.8B | 52% |
Annual Yield % from dividends | 0.21 | 0.60 | 34% |
Returns for 1 year | -9.38 | -5.01 | 187% |
Returns for 3 years | 17.88 | 24.73 | 72% |
Returns for 5 years | 17.19 | 5.95 | 289% |
Returns for 10 years | 57.91 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 14.06 | 0.48 | +3.50% |
ProShares UltraShort Nasdaq Biotech | |||
LODI | 25.33 | -0.02 | -0.06% |
AAM SLC Low Duration Income ETF | |||
FALN | 27.63 | -0.07 | -0.23% |
iShares Fallen Angels USD Bond ETF | |||
BKEM | 72.75 | -0.40 | -0.55% |
BNY Mellon Emerging Markets Equity ETF | |||
EIDO | 17.41 | -0.27 | -1.53% |
iShares MSCI Indonesia ETF |